What is the recommended dose of ondansetron (Zofran) for a 12-year-old child weighing 36kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ondansetron Dosing for a 36kg, 12-Year-Old Child

For a 12-year-old child weighing 36kg, administer ondansetron 0.15 mg/kg per dose, which equals 5.4 mg (can be rounded to 4 mg for practical administration using available tablet strengths), with a maximum single dose of 16 mg. 1, 2

Weight-Based Dosing Algorithm

  • For children weighing >23-40 kg: The standard dose is 0.15 mg/kg per dose 1, 2
  • For your 36kg patient: This calculates to 5.4 mg per dose 1, 2
  • Practical rounding: The dose can be rounded by up to 15% for practical administration, so 4 mg (one standard tablet) is acceptable and commonly used 1, 2
  • Alternative: If using the weight-based dosing table, children >23-40 kg receive 60 mg twice daily for treatment courses, but for single-dose antiemetic use, 4 mg is standard 1, 2

Route-Specific Administration

  • Oral route: 0.15 mg/kg/dose (4-6 mg for this patient), available as oral disintegrating tablets (ODT) or regular tablets 1, 2
  • Intravenous (IV) route: 0.15 mg/kg/dose (5.4 mg for this patient), maximum 16 mg single dose 1
  • Intramuscular (IM) route: 0.15 mg/kg/dose (5.4 mg for this patient), maximum 16 mg single dose 1

Dosing Frequency

  • Single dose: Most commonly used for acute nausea/vomiting 1, 2
  • Repeat dosing: Can be repeated every 8 hours as needed 2
  • Maximum daily dose: Do not exceed 16 mg per single dose regardless of weight-based calculation 1

Clinical Context Considerations

  • For acute gastroenteritis with moderate symptoms (>3 episodes of vomiting with mild lethargy): Administer ondansetron 0.15 mg/kg IM or oral 1
  • For postoperative nausea/vomiting: 0.1-0.15 mg/kg IV is effective 3, 4
  • For chemotherapy-induced nausea: Multiple doses of 0.15 mg/kg may be used 3, 5

Safety Considerations and Contraindications

  • Age restriction: Only use in children ≥6 months of age 1
  • Cardiac concerns: Exercise special caution in children with heart disease due to potential QT interval prolongation 1
  • Avoid in: Children with known cardiac conduction abnormalities without cardiology consultation 1

Common Pitfalls to Avoid

  • Do not exceed 16 mg as a single dose, even if weight-based calculation suggests higher 1
  • Do not use in infants <6 months old, as safety data are insufficient 1
  • Monitor for diarrhea: Ondansetron may increase diarrhea episodes in gastroenteritis patients 6
  • Watch for headache: The most common adverse effect, though generally mild 3, 4

Practical Administration Tips

  • Oral disintegrating tablets (ODT) are preferred for children who may have difficulty swallowing or ongoing nausea 2, 3
  • Administer 15 minutes before oral rehydration in gastroenteritis cases 6
  • Can be given without regard to meals, though administration with food may improve tolerability 3

Expected Efficacy

  • In gastroenteritis: Reduces median vomiting episodes to 0 during ED observation, decreases IV fluid requirements, and lowers admission rates 6
  • In postoperative setting: Superior to placebo, droperidol, and metoclopramide for preventing emesis 3
  • Onset of action: Peaks 1 hour after oral dose with half-life of 3.5 hours 4

References

Guideline

Ondansetron Dosing Guidelines for Infants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ondansetron Dosing for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Ondansetron: a novel antiemetic agent.

Southern medical journal, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.